Key result
Juvenile idiopathic inflammatory myopathy associates with higher urinary metabolite-to-creatinine ratios versus healthy controls.
Why the study?
Novel markers of muscle damage in juvenile idiopathic inflammatory myopathy were assessed using urinary muscle metabolites detected by 1H magnetic resonance spectroscopy.
Do urinary muscle metabolites correlate with disease damage in patients with juvenile idiopathic inflammatory myopathy?
Case-Control (n=80)
Do urinary muscle metabolites correlate with disease damage in patients with juvenile idiopathic inflammatory myopathy?
Urinary muscle metabolites, particularly the creatine to creatinine ratio, are elevated in juvenile idiopathic inflammatory myopathy and may serve as a non-invasive biomarker for disease damage.
Hypothesis-generating for urinary metabolites as biomarkers in juvenile myositis; leaves open prospective validation before clinical use.
OBJECTIVE: To assess for novel markers of muscle damage using urinary muscle metabolites by 1H magnetic resonance spectroscopy in patients with juvenile idiopathic inflammatory myopathy (IIM). METHODS: Creatine (Cr), choline (Cho), betaine (Bet), glycine (Gly), trimethylamine oxide (TMAO), and several other metabolites were measured in first morning void urine samples from 45 patients with juvenile IIM and from 35 healthy age-matched controls, and correlated with measures of myositis disease activity and damage. Urinary metabolite to age-adjusted creatinine (Cn) ratios were examined. RESULTS: Age-adjusted initial Cr:Cn, Cho:Cn, Bet:Cn, Gly:Cn, and TMAO:Cn ratios were higher in patients with juvenile IIM than controls (P < 0.01). Cr:Cn ratios showed significant correlations with physician-assessed global disease damage (Spearman rs = 0.37; P = 0.01), Steinbrocker functional class (rs = 0.35; P = 0.02), serum Cr (rs = 0.72; P = 0.001), and lactate dehydrogenase (rs = 0.34; P = 0.03) levels. Cho:Cn (rs = 0.3; P = 0.05), Gly:Cn (rs = 0.33; P = 0.03), and TMAO:Cn (rs = 0.36; P = 0.02) ratios showed a significant correlation with serum aldolase levels. Cho:Cn ratios also showed a significant correlation with aspartate aminotransferase levels (rs = 0.35; P = 0.02). A linear regression model was used to evaluate the factors influencing urinary Cr:Cn ratios in the 43 patients with data sets available at the initial visit. The regression model explained 73% of the variation in Cr:Cn ratios. The most significant factor was the physician-assessed global disease damage (R2 = 0.50, P = 0.015). CONCLUSION: Urinary Cr:Cn, Cho:Cn, Bet:Cn, Gly:Cn, and TMAO:Cn ratios are elevated in juvenile IIM and Cr:Cn correlates strongly with global disease damage. The Cr:Cn ratio may have potential utility as a marker of myositis disease damage.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2005) conducted a case-control in Juvenile idiopathic inflammatory myopathy (IIM) (n=80). Juvenile idiopathic inflammatory myopathy vs. Healthy age-matched controls was evaluated on Urinary metabolite to age-adjusted creatinine ratios (Cr:Cn, Cho:Cn, Bet:Cn, Gly:Cn, and TMAO:Cn) (p=< 0.01). Urinary metabolite to creatinine ratios were significantly higher in patients with juvenile idiopathic inflammatory myopathy compared to healthy controls (P < 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: